Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein-Barr virus infection
- PMID: 26723518
- DOI: 10.1016/j.imbio.2015.12.007
Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein-Barr virus infection
Abstract
Considerable data implicate the thymus as the main site of autosensitization to the acetylcholine receptor in myasthenia gravis (MG), a B-cell-mediated autoimmune disease affecting the neuromuscular junction. We recently demonstrated an active Epstein-Barr virus (EBV) infection in the thymus of MG patients, suggesting that EBV might contribute to the onset or maintenance of the autoimmune response within MG thymus, because of its ability to activate and immortalize autoreactive B cells. EBV has been reported to elicit and modulate Toll-like receptor (TLR) 7- and TLR9-mediated innate immune responses, which are known to favor B-cell dysfunction and autoimmunity. Aim of this study was to investigate whether EBV infection is associated with altered expression of TLR7 and TLR9 in MG thymus. By real-time PCR, we found that TLR7 and TLR9 mRNA levels were significantly higher in EBV-positive MG compared to EBV-negative normal thymuses. By confocal microscopy, high expression levels of TLR7 and TLR9 proteins were observed in B cells and plasma cells of MG thymic germinal centers (GCs) and lymphoid infiltrates, where the two receptors co-localized with EBV antigens. An increased frequency of Ki67-positive proliferating B cells was found in MG thymuses, where we also detected proliferating cells expressing TLR7, TLR9 and EBV antigens, thus supporting the idea that EBV-associated TLR7/9 signaling may promote abnormal B-cell activation and proliferation. Along with B cells and plasma cells, thymic epithelium, plasmacytoid dendritic cells and macrophages exhibited enhanced TLR7 and TLR9 expression in MG thymus; TLR7 was also increased in thymic myeloid dendritic cells and its transcriptional levels positively correlated with those of interferon (IFN)-β. We suggested that TLR7/9 signaling may be involved in antiviral type I IFN production and long-term inflammation in EBV-infected MG thymuses. Our overall findings indicate that EBV-driven TLR7- and TLR9-mediated innate immune responses may participate in the intra-thymic pathogenesis of MG.
Keywords: Epstein–Barr virus; Myasthenia gravis; Thymus; Toll-like receptor 7; Toll-like receptor 9.
Copyright © 2015 Elsevier GmbH. All rights reserved.
Similar articles
-
Toll-like receptors 7 and 9 in myasthenia gravis thymus: amplifiers of autoimmunity?Ann N Y Acad Sci. 2018 Feb;1413(1):11-24. doi: 10.1111/nyas.13534. Epub 2018 Jan 24. Ann N Y Acad Sci. 2018. PMID: 29363775 Review.
-
Epstein-Barr virus persistence and reactivation in myasthenia gravis thymus.Ann Neurol. 2010 Jun;67(6):726-38. doi: 10.1002/ana.21902. Ann Neurol. 2010. PMID: 20517934
-
Manipulation of the toll-like receptor 7 signaling pathway by Epstein-Barr virus.J Virol. 2007 Sep;81(18):9748-58. doi: 10.1128/JVI.01122-07. Epub 2007 Jul 3. J Virol. 2007. PMID: 17609264 Free PMC article.
-
miR-146a in Myasthenia Gravis Thymus Bridges Innate Immunity With Autoimmunity and Is Linked to Therapeutic Effects of Corticosteroids.Front Immunol. 2020 Mar 10;11:142. doi: 10.3389/fimmu.2020.00142. eCollection 2020. Front Immunol. 2020. PMID: 32210951 Free PMC article.
-
Thymus involvement in early-onset myasthenia gravis.Ann N Y Acad Sci. 2018 Jan;1412(1):137-145. doi: 10.1111/nyas.13519. Epub 2017 Nov 10. Ann N Y Acad Sci. 2018. PMID: 29125185 Review.
Cited by
-
Role of miRNAs in Normal and Myasthenia Gravis Thymus.Front Immunol. 2020 Jun 10;11:1074. doi: 10.3389/fimmu.2020.01074. eCollection 2020. Front Immunol. 2020. PMID: 32587589 Free PMC article. Review.
-
Epstein-Barr virus in tumor-infiltrating B cells of myasthenia gravis thymoma: an innocent bystander or an autoimmunity mediator?Oncotarget. 2017 Sep 8;8(56):95432-95449. doi: 10.18632/oncotarget.20731. eCollection 2017 Nov 10. Oncotarget. 2017. PMID: 29221139 Free PMC article.
-
Autoimmune myasthenia gravis and COVID-19. A case report-based review.J Int Med Res. 2023 Aug;51(8):3000605231191025. doi: 10.1177/03000605231191025. J Int Med Res. 2023. PMID: 37565671 Free PMC article. Review.
-
To Be or Not To Be Vaccinated: That Is a Question in Myasthenia Gravis.Front Immunol. 2021 Sep 17;12:733418. doi: 10.3389/fimmu.2021.733418. eCollection 2021. Front Immunol. 2021. PMID: 34603311 Free PMC article. Review.
-
Use of Toll-Like Receptor Agonists to Induce Ectopic Lymphoid Structures in Myasthenia Gravis Mouse Models.Front Immunol. 2017 Aug 25;8:1029. doi: 10.3389/fimmu.2017.01029. eCollection 2017. Front Immunol. 2017. PMID: 28970832 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical